Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Benz

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Investigative Radiology|October 1, 1990
Magnetic resonance imaging of implanted melanomas before and after chemotherapy. Relation to 31P magnetic resonance spectroscopy and tumor histologyS B Iyer, H I Goldberg, C C Benz
The Journal of Biological Chemistry|May 3, 1996
Evidence of post-transcriptional regulation of U6 small nuclear RNAS B Noonberg, G K Scott, C C Benz
Clinical Pharmacokinetics|September 1, 1988
Clinical pharmacokinetics of drugs used in the treatment of breast cancerV J Wiebe, C C Benz, M W DeGregorio
The British Journal of Dermatology|July 1, 1977
Acquired chronic candidiasis treated with transfer factorC C Benz, J W Thomas, M Mandl, et al.
Endocrine-Related Cancer|August 23, 2005
The NFkappaB pathway and endocrine-resistant breast cancerY Zhou, S Eppenberger-Castori, U Eppenberger, et al.
The Journal of Clinical Investigation|August 1, 1991
Truncated forms of DNA-binding estrogen receptors in human breast cancerG K Scott, P Kushner, J L Vigne, et al.
Free Radical Biology & Medicine|June 1, 1994
Oxidant-sensitive protein phosphorylation in endothelial cellsA Barchowsky, M E Williams, C C Benz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistanceM W DeGregorio, J M Ford, C C Benz, et al.
Journal of the National Cancer Institute|November 15, 1989
Expression of c-myc, c-Ha-ras1, and c-erbB-2 proto-oncogenes in normal and malignant human breast epithelial cellsC C Benz, G K Scott, G F Santos, et al.
Oncogene|July 3, 1999
Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP)C H Chang, G K Scott, M A Baldwin, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Investigative Radiology|October 1, 1990
Magnetic resonance imaging of implanted melanomas before and after chemotherapy. Relation to 31P magnetic resonance spectroscopy and tumor histologyS B Iyer, H I Goldberg, C C Benz
The Journal of Biological Chemistry|May 3, 1996
Evidence of post-transcriptional regulation of U6 small nuclear RNAS B Noonberg, G K Scott, C C Benz
Clinical Pharmacokinetics|September 1, 1988
Clinical pharmacokinetics of drugs used in the treatment of breast cancerV J Wiebe, C C Benz, M W DeGregorio
The British Journal of Dermatology|July 1, 1977
Acquired chronic candidiasis treated with transfer factorC C Benz, J W Thomas, M Mandl, et al.
Endocrine-Related Cancer|August 23, 2005
The NFkappaB pathway and endocrine-resistant breast cancerY Zhou, S Eppenberger-Castori, U Eppenberger, et al.
The Journal of Clinical Investigation|August 1, 1991
Truncated forms of DNA-binding estrogen receptors in human breast cancerG K Scott, P Kushner, J L Vigne, et al.
Free Radical Biology & Medicine|June 1, 1994
Oxidant-sensitive protein phosphorylation in endothelial cellsA Barchowsky, M E Williams, C C Benz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistanceM W DeGregorio, J M Ford, C C Benz, et al.
Journal of the National Cancer Institute|November 15, 1989
Expression of c-myc, c-Ha-ras1, and c-erbB-2 proto-oncogenes in normal and malignant human breast epithelial cellsC C Benz, G K Scott, G F Santos, et al.
Oncogene|July 3, 1999
Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP)C H Chang, G K Scott, M A Baldwin, et al.
Pageof 8